Results 181 to 190 of about 6,644,019 (302)

Utilizing rapid diagnostic tests in infectious disease surveillance and response in humanitarian emergencies. [PDF]

Front Public Health
Herilla ME, Townes DA, Boyd AT.
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Infectious Disease Provider Perspectives on Shorter Tuberculosis Treatment Regimens. [PDF]

Open Forum Infect Dis
Moreira A, Hassneiah D, Beekmann SE, Polgreen P, Shah M, Nathavitharana RR.   +5 more
europepmc   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Using Probabilistic Cellular Automata to Model the Transmission of an Emerging Infectious Disease of Amphibians-A Preliminary Model. [PDF]

Pathogens
Duffus ALJ, Standridge JP, Bartlett PL, George JC.   +3 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Crisis and Emergency Risk Communication in an infectious disease outbreak

Crisis and Emergency Risk Communication in an infectious disease outbreak.CS2922228-APublication date from document properties.CERC_Infectious_Diseases_FactSheet ...

core  

Characterizing the impact of incorporating spatially aggregated human mobility data into infectious disease models. [PDF]

Proc Natl Acad Sci U S A
Corgel R, Grantz KH, Gardner L, Cummings DAT, de Silva H, Somaratne T, Silva D, Fernando L, Wesolowski A.   +8 more
europepmc   +1 more source

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuralgic amyotrophy (NA) is a prevalent, monophasic, multifocal immune‐mediated neuropathy. A distinctive characteristic of the disease is the occurrence of nerve or fascicle constrictions and torsions (NA‐associated focal nerve lesions, NAFL). The pathophysiology underlying this phenomenon remains to be fully elucidated.
Johannes Fabian Holle, Andreas Leha, Volker Limmroth, Wolfram Windisch, Maximilian Zimmermann   +4 more
wiley   +1 more source

Resilience of health systems in Africa to infectious disease shocks: A qualitative evidence synthesis. [PDF]

PLOS Glob Public Health
Okethwangu D, Ahirirwe S, Venkateswaran M, Mayega R, Rutebemberwa E, Ocom F, Nankabirwa V, Okot CL, Nyachwo EB, Nabatanzi S, Asio E, Mohammed UN, Ario AR, Forland F, Kiwanuka SN.   +14 more
europepmc   +1 more source